DermaGold®: Revolutionizing Wound Care with Patented Technology
SoftWave TRT uses patented technology to reach an injured area at the cellular level to successfully turn on the body’s natural healing process.
SoftWave’s DermaGold® is at the forefront of advanced wound care, utilizing patented technology to stimulate the body’s natural healing process at the cellular level. This breakthrough approach accelerates healing, making it a game-changer in the treatment of various wound types.
- Faster wound healing compared to standard care
- Non-invasive treatment ensures patient comfort
- Versatile adjunct therapy, effective alone or in combination with other treatments
- Reduces complications and can lower amputation rates
EFFECTIVE
- Faster wound healing than the standard of care
- Non-invasive
- Adjunct therapy can be used alone or in combination with other Advanced Wound Care
- Decreases complications and amputation rates
PROVEN
- FDA Cleared to treat DFUs
- Reimbursement Pathway with CPT codes 0512T and 0513T
- Less costly than HBOT, NPWT, Skin Substitutes
CONVENIENT
- Fast and easy to use
- Used in an office/wound clinic/outpatient setting
- Mobile unit fits seamlessly within wound care clinic
- Does not require a sterile environment
- Average treatment time is less than 10 minutes
- Once-a-week treatment
SoftWave triggers biological responses
SoftWave produces a biological response that accelerates angiogenesis and revascularization which promotes faster wound healing.
Click on the above image to access our White Paper
SoftWave initiates a more rapid and effective healing phase.
It is thought to work by:
- Increasing the blood flow to the wounded area
- Stimulating the neovascularization and growth factors
- Modulating the inflammatory process
- Stimulating osteoclasts and fibroblasts to rebuild injured tissue
- Facilitating resorption of calcification in tendons and ligaments
- Stimulating the migration of resident stem cells
Trusted and Researched
Articles
Use DermaGold 100® to accelerate healing
DERMAGOLD: FASTER AND MORE EFFECTIVE WOUND CARE
DermaGold® offers a superior solution for chronic non-healing wounds with patented technology, leading to better outcomes and higher client satisfaction:
- Effective: Clinically proven to expedite wound healing, surpassing traditional methods.
- Proven: FDA cleared for the treatment of Diabetic Foot Ulcers (DFUs), with established reimbursement pathways via CPT codes 0512T and 0513T.
- Cost-Effective: A more economical solution compared to Hyperbaric Oxygen Therapy (HBOT), Negative Pressure Wound Therapy (NPWT), and skin substitutes.
- Convenient: Quick and straightforward application with an average treatment time of under 10 minutes, suitable for once-a-week sessions. The mobility of the unit ensures it can be effortlessly integrated into any office, wound clinic, or outpatient setting without the need for a sterile environment.
FAQs On DermaGold
DermaGold® utilizes patented shockwave technology to accelerate natural healing processes at the cellular level, making it a non-invasive, effective treatment for wounds. Unlike traditional therapies, DermaGold® is FDA-cleared for treating Diabetic Foot Ulcers (DFUs), offering a faster, cost-effective solution without the need for a sterile environment. The technology reaches wider and deeper than other options for superior outcomes.
While DermaGold® is FDA-cleared specifically for Diabetic Foot Ulcers, its technology is beneficial for a wide range of wounds. Its non-invasive nature and mechanism of action make it a versatile tool in wound care, suitable for adjunct therapy either alone or in combination with other treatments. It’s advisable to evaluate the specific wound type and condition for compatibility.
Clinics adopting DermaGold® receive comprehensive training and support to ensure seamless integration into their practice. This includes operational training, best practice guidelines, and ongoing clinical support. The goal is to equip clinicians with the knowledge and skills needed to maximize the therapeutic benefits of DermaGold® for their patients.
Looking to
Purchase a
Shockwave
Therapy Machine?
Submit a Request
Fill out our Become a Provider Form to get started with a SoftWave representative
Explore Purchase Options
SoftWave is a GSA contract holder
Begin Treating Patients
SoftWave is easy to operate, does not require a physician, and suitable for use in non-clinical settings